Work

Emapalumab induces rapid, durable responses and reliable bridging to curative HSCT in patients with primary HLH: Pooled analysis of prospective trials NI-0501-04, NI-0501-05 and NI-0501-09

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-4758

Authors: Michael Jordan, Franco Locatelli, Didier Halimi, Elena Burillo, Brian Jamieson, Andrew Danquah, Emmanuel Monnet

Institutions: Cincinnati Children's Hospital Medical Center, University of Cincinnati, Università Cattolica del Sacro Cuore, Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico

Language: English

Topic: Autoimmune and Inflammatory Disorders Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417005209

Cites:

Cited by: 1

Related to: